pharmacogenomics

(redirected from Pharmacogenomic)
Also found in: Medical.

phar·ma·co·ge·no·mics

 (fär′mə-kō-jə-nō′mĭks)
n. (used with a sing. verb)
The study of inherited variations in genetic factors that influence a patient's metabolic response to a given drug, especially adverse side effects. Also called pharmacogenetics.

pharmacogenomics

(ˌfɑːməkəʊdʒɪˈnɒmɪks)
n (functioning as singular)
1. (Medicine) the study of human genetic variability in relation to drug action and its application to medical treatment
2. (Genetics) the study of human genetic variability in relation to drug action and its application to medical treatment
ˌpharmacogeˈnomic adj
Mentioned in ?
References in periodicals archive ?
8220;The fact that more and more doctors are realizing what pharmacogenomic testing can do for their patients is changing the approach to personalized medical care,” said GenToX CEO Matthew Bennett.
Assurex Health today announced that Medicare has issued a Local Coverage Determination (LCD) that will provide coverage for GeneSight Psychotropic, the first combinatorial pharmacogenomic test to help guide medication decisions for depression.
Among the topics are whether traditional therapeutic drug monitoring and pharmacogenomics are complementary, pharmacogenomic aspects of warfarin therapy, pharmacogenomic considerations in anesthesia and pain management, anti-retroviral therapy, psychoactive drugs, and microarray technology and other methods in pharmacogenomics testing.
As the antioxidant function of the Hp 2-2 protein is impaired, we sought to test the pharmacogenomic hypothesis that antioxidant vitamin E supplementation would provide cardiovascular protection to Hp 2-2 DM individuals.
VANCOUVER, November 5 /PRNewswire/ -- Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that it has signed its first Contribution Agreement with the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP).
Upcoming moves by the FDA could spur a number of pharmacogenomic studies for warfarin and eventually bring pharmacogenomic tests into the mainstream.
DNAPrint is developing products in the pharmacogenomic market and has a disease gene discovery program.
The FDA has recently issued a draft, "Guidance for Industry: Pharmacogenomic Data Submissions" (FDA 2003), and has held workshops to discuss issues related to pharmacogenomics data submissions (Salerno and Lesko 2004a, 2004b; Leighton et al.
28, 2013 /PRNewswire/ -- Assurex Health, a leading personalized medicine company, announced today that the International Review of Psychiatry published an extensive review that validates the clinical use of pharmacogenomic testing to help predict patient response to psychiatric medications and improve treatment outcomes.
0, its lead psychiatric pharmacogenomic test panel.
AUSTIN, Texas -- Asuragen Pharmacogenomic Services, a division of Asuragen, Inc.
AssureRx Health is the exclusive worldwide licensee of the technology covered under this patent and has developed pharmacogenomic tests commercialized under the brand GeneSight.